ストックスクリーナーアプリを入手
10.39
0.10%
-0.010
アフターアワーズ：
10.26
-0.13
-1.25%
Amneal Pharmaceuticals Inc (AMRX) 最新ニュース
Amneal Pharmaceuticals Hits New 52-Week High of $10.43 - Markets Mojo
Amneal Pharmaceuticals, Inc. (AMRX) Files BLA for XOLAIR® Biosimilar, Targets Multi-Billion-Dollar Market - MSN
Sentiment analysis tools applied to Amneal Pharmaceuticals Inc.2025 Price Targets & Weekly High Return Stock Opportunities - newser.com
What to expect from Amneal Pharmaceuticals Inc. in the next 30 daysQuarterly Market Review & Accurate Buy Signal Notifications - newser.com
Will breakout in Amneal Pharmaceuticals Inc. lead to full recoveryTrade Entry Report & Short-Term Trading Opportunity Alerts - newser.com
Measuring Amneal Pharmaceuticals Inc.’s beta against major indicesDay Trade & Capital Efficiency Focused Strategies - newser.com
Is Amneal Pharmaceuticals Inc. stock cheap compared to fundamentalsEarnings Growth Report & Safe Entry Zone Identification - newser.com
Chart based exit strategy for Amneal Pharmaceuticals Inc.Market Volume Summary & Smart Investment Allocation Insights - newser.com
Reversal indicators forming on Amneal Pharmaceuticals Inc. stockInsider Buying & Real-Time Market Trend Scan - newser.com
Will Amneal Pharmaceuticals Inc. price bounce be sustainable2025 Big Picture & AI Forecasted Stock Moves - newser.com
Using Python tools to backtest Amneal Pharmaceuticals Inc. strategiesQuarterly Earnings Summary & Stepwise Trade Execution Plans - newser.com
What analysts say about Amneal Pharmaceuticals Inc stockGap Up/Gap Down Analysis & Free Take Advantage Of Momentum - earlytimes.in
Are Medical Stocks Lagging Amneal Pharmaceuticals (AMRX) This Year? - sharewise.com
3 Lesser-Known Healthcare Names With Major Upside in Store - sharewise.com
3 Lesser-Known Healthcare Names With Major Upside in Store - Investing.com
Amneal Pharmaceuticals stock hits 52-week high at $10.36 By Investing.com - Investing.com Canada
Amneal Pharmaceuticals stock hits 52-week high at $10.36 - Investing.com
Technical analysis overview for Amneal Pharmaceuticals Inc. stock2025 Big Picture & Technical Buy Zone Confirmations - newser.com
Published on: 2025-10-01 09:03:57 - newser.com
Is it time to cut losses on Amneal Pharmaceuticals Inc.2025 Market Sentiment & Breakout Confirmation Alerts - newser.com
Applying Wyckoff theory to Amneal Pharmaceuticals Inc. stock2025 Momentum Check & Verified High Yield Trade Plans - newser.com
Amneal to Report Third Quarter 2025 Results on October 30, 2025 - The Manila Times
Global Biopharma Amneal Pharmaceuticals Schedules Q3 2025 Financial Results and Investor Conference - Stock Titan
Amneal Files Xolair Biosimilar In US ‘Earlier Than Expected’ - insights.citeline.com
Amneal Pharmaceuticals Inc Stock Analysis and ForecastDividend Stability Analysis & Explosive Profit Trading - earlytimes.in
How to read the order book for Amneal Pharmaceuticals Inc.2025 Institutional Moves & Fast Exit Strategy with Risk Control - newser.com
What drives Amneal Pharmaceuticals Inc stock priceRisk-Reward Ratio Analysis & Low Cost Stock Picks - Early Times
Amneal gets FDA nod for generic version of Risperdal Consta - MSN
Amneal submits biosimilar application for asthma drug Xolair - Investing.com India
Amneal submits biosimilar application for asthma drug Xolair By Investing.com - Investing.com South Africa
Amneal seeks FDA nod for generic targeting Xolair marketed by Roche and Novartis - Seeking Alpha
Amneal Announces BLA Submission of Biosimilar Candidate to XOLAIR® (omalizumab) - The Manila Times
Amneal announces BLA submission of biosimilar candidate to Xolair (omalizumab) - MarketScreener
$4.1 Billion Market Opportunity: Amneal's XOLAIR Biosimilar Filing Could Transform Asthma Treatment Access - Stock Titan
0.83%
9.21%
大文字化:
|
ボリューム (24 時間):